Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.
Angiogenesis occurs during embryogenesis and is a down-regulated process in the healthy adult that is almost exclusively linked to pathological conditions such as tumor growth, wound healing, and inflammation. Physiological angiogenic processes in the adult are restricted to the female reproductive system where they occur cyclically during the ovarian and uterine cycle as well as during pregnancy. By systematically analyzing the phenotypic changes of endothelial cells during bovine corpus luteum (CL) formation and regression, we have established a physiological model of blood vessel growth and regression. Quantitation of vessel density, percentage of vessels with lumen, and ratio of Bandeiraea simplicifolia-I to von Willebrand Factor-positive endothelial cells were established as parameters of angiogenesis. Sprouting endothelial cells invade the growing CL and continue to grow throughout the first third of the ovarian cycle. Thereafter the mature CL is characterized by a dense network of vessels with gradually decreasing vessel density. During luteolysis and for several weeks thereafter (regressing and residual CL) all newly formed vessels regress, which is accompanied by gradual foreshortening and rounding of endothelial cells and subsequent detachment. Based on histochemical detection of nucleosomal fragmentation products physiological blood vessel regression in the cyclic CL does not appear to involve endothelial cell apoptosis. Lectin histochemical analysis revealed a distinct alteration of endothelial cell glycoconjugate expression during ovarian angiogenesis comparable with the distinct pattern of hyperglycosylation of cultured migrating endothelial cells (up-regulation of binding sites for Lycopersicon esculentum lectin, wheat germ agglutinin, neuraminidase-treated peanut agglutinin, and Ricinus communis agglutinin-I on sprouting ECs). Northern blot analysis of glycosyltransferases during the different stages of angiogenesis revealed an up-regulation of beta-galactoside alpha 2,6-sialyltransferase and alpha 1,3-galactosyltransferase mRNA expression during the angiogenic stages of CL formation. These data establish the ovarian angiogenesis model as a suitable experimental system to study the functional and phenotypic properties of endothelial cells in sprouting and regressing blood vessels and provide additional evidence for the importance of endothelial cell surface glycoconjugates during angiogenesis.
Augustin
H G
HG
Department of Gynaecology and Obstetrics, University of Göttingen Medical School, Germany.
Braun
K
K
Telemenakis
I
I
Modlich
U
U
Kuhn
W
W
D000818:Animals; D001483:Base Sequence; D001808:Blood Vessels / Q000254:growth & development* / Q000502:physiology; D002417:Cattle; D003338:Corpus Luteum / Q000098:blood supply / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D004971:Estrus; D005260:Female; D016695:Glycosyltransferases / Q000235:genetics; D006651:Histocytochemistry; D037102:Lectins; D003341:Luteolysis; D015335:Molecular Probes / Q000235:genetics; D008969:Molecular Sequence Data; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010053:Ovary / Q000098:blood supply*; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism
D037102:Lectins; D015335:Molecular Probes; D012333:RNA, Messenger; D016695:Glycosyltransferases